Cassian Sitaru Selected Research

Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)

10/2017	The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita.
9/2014	Blister-inducing antibodies target multiple epitopes on collagen VII in mice.
1/2013	Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
4/2012	Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases.
10/2010	Autoimmunity against type VII collagen in inflammatory bowel disease.
4/2010	Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.
3/2010	Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita.
2/2010	T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
8/2008	Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita.
6/2007	Experimental models of epidermolysis bullosa acquisita.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cassian Sitaru Research Topics

Disease

37	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2002
18	Blister (Bulla) 01/2022 - 04/2002
17	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 10/2017 - 06/2002
17	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 10/2002
12	Skin Diseases (Skin Disease) 01/2021 - 09/2004
10	Pemphigus (Pemphigus Vulgaris) 04/2018 - 06/2002
7	Inflammation (Inflammations) 01/2022 - 07/2002
5	Pemphigoid Gestationis (Herpes Gestationis) 04/2015 - 01/2002
3	Neoplasms (Cancer) 01/2018 - 04/2014
3	Arthritis (Polyarthritis) 04/2016 - 04/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2012 - 03/2005
3	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 04/2007 - 09/2006
3	Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid) 12/2004 - 01/2002
2	Lichen Planus (Lichen Ruber Planus) 01/2018 - 01/2002
2	Wounds and Injuries (Trauma) 02/2016 - 02/2016
2	Vasculitis (Vasculitides) 01/2016 - 01/2014
2	Dermatitis Herpetiformis (Disease, Duhring's) 12/2012 - 05/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012 - 06/2002
2	Acantholysis 04/2007 - 12/2005
1	Pruritus (Itching) 01/2021
1	Sudden Infant Death (SID) 04/2018
1	Diabetes Mellitus 04/2018
1	Dermatitis 04/2016
1	Burns 02/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2016
1	Insect Bites and Stings (Insect Bite) 02/2016
1	Coronary Disease (Coronary Heart Disease) 04/2015
1	Cardiac Arrhythmias (Arrythmia) 04/2015
1	Arthus Reaction 09/2014
1	Cutaneous Lupus Erythematosus 02/2014
1	Infections 02/2014
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2014
1	Chagas Disease (American Trypanosomiasis) 02/2014
1	Hypersensitivity (Allergy) 01/2013
1	Skin Neoplasms (Skin Cancer) 01/2013
1	Celiac Disease (Celiac Sprue) 12/2012
1	Lung Neoplasms (Lung Cancer) 12/2012
1	Autoimmune Pancreatitis 12/2012
1	Rare Diseases (Rare Disease) 05/2011
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 02/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2006
1	Epidermolysis Bullosa 06/2006
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 06/2006
1	Cicatrix (Scar) 02/2006

Drug/Important Bio-Agent (IBA)

61	AutoantibodiesIBA 01/2022 - 01/2002
19	AntigensIBA 01/2018 - 04/2002
17	Immunoglobulin G (IgG)IBA 01/2021 - 04/2002
16	Collagen Type XVIIIBA 01/2022 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 04/2014 - 01/2002
13	AntibodiesIBA 10/2017 - 04/2002
10	Collagen Type VIIIBA 10/2017 - 07/2002
8	CollagenIBA 09/2014 - 02/2007
7	AutoantigensIBA 01/2021 - 12/2003
7	KalininIBA 01/2018 - 06/2002
6	Immunoglobulin A (IgA)IBA 01/2022 - 07/2004
6	EpitopesIBA 09/2014 - 04/2002
5	Complement System Proteins (Complement)IBA 01/2018 - 04/2002
4	Laminin (Merosin)IBA 01/2018 - 02/2014
2	Desmoglein 1IBA 04/2018 - 12/2006
2	Desmoglein 3IBA 01/2018 - 12/2006
2	src-Family KinasesIBA 10/2017 - 09/2014
2	ChemokinesIBA 04/2016 - 12/2004
2	TransglutaminasesIBA 12/2012 - 05/2011
2	N 30IBA 05/2011 - 06/2002
2	neonatal Fc receptorIBA 08/2010 - 08/2008
2	ImmunosorbentsIBA 09/2007 - 04/2004
2	EnzymesIBA 09/2007 - 04/2004
2	Glycoproteins (Glycoprotein)IBA 05/2005 - 12/2003
1	Monoclonal AntibodiesIBA 01/2022
1	Cortisone FDA Link 04/2018
1	SteroidsIBA 04/2018
1	GlucocorticoidsIBA 04/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 04/2018
1	Complement C3 (C3 Complement)IBA 01/2018
1	Syk KinaseIBA 10/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2017
1	Leukotriene B4IBA 10/2017
1	CytokinesIBA 04/2016
1	LipidsIBA 04/2016
1	IntegrinsIBA 09/2014
1	Phosphotransferases (Kinase)IBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Rituximab (Mabthera)FDA Link 04/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2012
1	FlavonoidsIBA 01/2012
1	LuteolinIBA 01/2012
1	Immunoglobulin E (IgE)IBA 05/2011
1	Peptides (Polypeptides)IBA 10/2010
1	MetalsIBA 03/2010
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 08/2009
1	DesmocollinsIBA 12/2006
1	CalciumIBA 11/2006
1	Prednisolone (Predate)FDA LinkGeneric 02/2006
1	Dapsone FDA Link 02/2006

Therapy/Procedure

7	Therapeutics 04/2018 - 09/2004
1	Duration of Therapy 04/2018
1	Operative Surgical Procedures 02/2016
1	Radiotherapy 02/2016
1	Investigational Therapies (Experimental Therapy) 01/2013
1	Immunomodulation 09/2006